商品
搜索
首页
百科
(S)-4-(3-Iodo-propyl)-2,2,4-trimethyl-[1,3]dioxolane
CAS号:77518-19-5
英文名:(S)-4-(3-Iodo-propyl)-2,2,4-trimethyl-[1,3]dioxolane
分子式
C9H17IO2
熔点
密度
分子量
284.135
沸点
溶解度
信号词
危险品标志
若想填写更详细的询价信息,请
点击进入询价页面
点我
产品名称/CAS号
纯度
需求量
立即询价
基本信息
中文名称
(S)-4-(3-Iodo-propyl)-2,2,4-trimethyl-[1,3]dioxolane
英文名称
(S)-4-(3-Iodo-propyl)-2,2,4-trimethyl-[1,3]dioxolane
中文别名
英文别名
CAS号
77518-19-5
分子式
C9H17IO2
分子量
284.135
精确质量
284.027
PSA
18.46
LOGP
2.7432
下游产品
共找到
10
个下游商品 >
82182-38-5
(R)-2-[(3S,8S,9S,10R,13S,14S,17R)-10,13-Dimethyl-3-(tetrahydro-pyran-2-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-((S)-2,2,4-trimethyl-[1,3]dioxolan-4-yl)-pentan-1-ol
67528-77-2
(25S)-3β,25,26-trihydroxycholest-5-ene
82182-39-6
Toluene-4-sulfonic acid (R)-2-[(3S,8S,9S,10R,13S,14S,17R)-10,13-dimethyl-3-(tetrahydro-pyran-2-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-((S)-2,2,4-trimethyl-[1,3]dioxolan-4-yl)-pentyl ester
42737-55-3
(25S)-cholesta-5,7-dien-3β,25,26-triol
56009-11-1
(1R,3aS,7aR)-1-((1R,5S)-1,5-Dimethyl-5,6-bis-trimethylsilanyloxy-hexyl)-7a-methyl-4-[2-[(S)-2-methylene-5-trimethylsilanyloxy-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-octahydro-indene
77518-21-9
2-{(3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(R)-1-methyl-4-((S)-2,2,4-trimethyl-[1,3]dioxolan-4-yl)-butyl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy}-tetrahydro-pyran
下游产品
(R)-2-[(3S,8S,9S,10R,13S,14S,17R)-10,13-Dimethyl-3-(tetrahydro-pyran-2-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-((S)-2,2,4-trimethyl-[1,3]dioxolan-4-yl)-pentan-1-ol
(25S)-3β,25,26-trihydroxycholest-5-ene
Toluene-4-sulfonic acid (R)-2-[(3S,8S,9S,10R,13S,14S,17R)-10,13-dimethyl-3-(tetrahydro-pyran-2-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-((S)-2,2,4-trimethyl-[1,3]dioxolan-4-yl)-pentyl ester
(25S)-cholesta-5,7-dien-3β,25,26-triol
(1R,3aS,7aR)-1-((1R,5S)-1,5-Dimethyl-5,6-bis-trimethylsilanyloxy-hexyl)-7a-methyl-4-[2-[(S)-2-methylene-5-trimethylsilanyloxy-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-octahydro-indene
2-{(3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(R)-1-methyl-4-((S)-2,2,4-trimethyl-[1,3]dioxolan-4-yl)-butyl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy}-tetrahydro-pyran
25(S),26-Dihydroxyvitamin D3
(25R)-1α,25,26-trihydroxycholesterol
(R)-2-[(3S,8S,9S,10R,13S,14S,17R)-10,13-Dimethyl-3-(tetrahydro-pyran-2-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-((S)-2,2,4-trimethyl-[1,3]dioxolan-4-yl)-pentanoic acid ethyl ester
ethyl (2R)-2-((1S,3R,8S,9S,10R,13S,14S,17R)-10,13-dimethyl-1,3-bis((tetrahydro-2H-pyran-2-yl)oxy)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-5-((S)-2,2,4-trimethyl-1,3-dioxolan-4-yl)pentanoate